WHO guidelines for plague management : revised recommendations for the use of rapid diagnostic tests, fluoroquinolones for case management and personal protective equipment for prevention of post-mortem transmission

WHO guidelines for plague management revised recommendations for the use of rapid diagnostic tests, fluoroquinolones for case management and personal protective equipment for prevention of post-mortem transmission

Detalles Bibliográficos
Autor principal: World Health Organization (author)
Autor Corporativo: World Health Organization, author, issuing body (author)
Formato: Libro electrónico
Idioma:Inglés
Publicado: Geneva : World Health Organization [2021]
Edición:1st ed
Materias:
Plague > History.
Disease management.
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009624054406719
Tabla de Contenidos:
  • Intro
  • Acknowledgements
  • Abbreviations
  • Executive summary
  • Introduction
  • 1.1 Background
  • 1.2 Rationale for these guidelines
  • 1.3 Target audience
  • 1.4 Aim and objective
  • Guideline development process and methods
  • 2.1 Scoping and developing key questions
  • 2.2 Contributors to the guideline development process
  • 2.3 Declarations of interests
  • 2.4 Identifying, appraising and synthesizing evidence
  • 2.5 Formulating recommendations
  • 2.5.1 Evidence-to-decision considerations
  • 2.5.2 Group decision-making
  • 2.6 Peer review
  • 2.7 Stakeholders and the public
  • 2.8 Guiding principles
  • Recommendations
  • 3.1 Use of F1RDT for plague
  • 3.1.1 Background
  • 3.1.2 Use of F1RDT to detect pneumonic plague in plague-endemic areas
  • 3.1.3 Use of F1RDT to diagnose pneumonic plague in patients in areas where an outbreak is in progress
  • 3.1.4 Use of F1RDT to detect bubonic plague in plague-endemic areas
  • 3.1.5 Use of F1RDT to diagnose bubonic plague in patients in areas where an outbreak is in progress
  • 3.2 Antibiotics for treating plague
  • 3.2.1 Background
  • 3.2.2 Development of recommendations on antibiotics for treating plague
  • 3.2.3 Supporting evidence
  • 3.2.4 Use of fluoroquinolones for treating pneumonic or septicaemic plague
  • 3.2.5 Use of doxycycline for treating pneumonic or septicaemic plague
  • 3.2.6 Use of fluoroquinolones for treating bubonic plague
  • 3.2.7 Use of fluoroquinolones for treating plague meningitis
  • 3.2.8 Use of fluoroquinolones for postexposure presumptive treatment
  • 3.2.9 Antibiotics for pre-exposure chemoprophylaxis
  • 3.3 Use of personal protective equipment
  • 3.3.1 Background
  • Monitoring and evaluation
  • Knowledge gaps and future research
  • 5.1 F1RDT for plague
  • 5.2 Antibiotics for treating plague.
  • 5.3 Risk of transmission from the dead body of a person who was infected with plague
  • 5.4 Recommendations for additional guidance
  • Updating
  • References.

Ejemplares similares